| Document Date: 2005-07-06 02:13:58
Open Document File Size: 54,57 KBShare Result on Facebook
City San Francisco / Montreal / Bristol / / Company Bristol Myers Squibb / / Country Canada / Australia / / / Event Product Recall / Product Issues / / Facility Arch Gen Psychiatry / Pharmacy Department / / IndustryTerm treatment of negative symptoms / food / / MedicalCondition insomnia / memory dysfunction / schizophrenia / cognitive symptoms / schizoaffective disorder / treatment resistant schizophrenia / psychoses / Acute Bipolar Mania / chronic / stable schizophrenia / schozphrenia and schizoaffective disorder / chronic schizophrenia / refractory schizophrenia / / MusicGroup Nausea / / Organization Congress / 156th American Psychiatric Association / Pharmacy Department / / Person Kate Smith / Johnson V. Aripiprazole / / Position Governor / / Product olanzapine / Clozapine / fluoxetine / phenytoin / above interacting drugs / haloperidol / dexamethasone / 30mg / carbamazepine / ketoconazole / risperidone / Abilify / erythromycin / omeprazole / / ProvinceOrState New Brunswick / California / /
SocialTag |
Aripiprazole – a new class of antipsychotic